SynthesisBMC cancer2021

Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.

Miao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.